Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	3-chloroallyl aldehyde dehydrogenase activity	ALDH3A1 ALDH3B1 ALDH3B2	2.89e-05	7	190	3	GO:0004028
GeneOntologyMolecularFunction	nucleocytoplasmic carrier activity	KPNB1 KPNA5 RANBP17 IPO9	2.32e-04	32	190	4	GO:0140142
GeneOntologyMolecularFunction	chromatin binding	CAMTA2 RXRB REC8 DDX12P RARA KDM5A POLR2B POU1F1 REST MORC2 CREB3L1 SFMBT2 ASXL3 SMARCB1 SMARCC1 ACTRT1 KAT6B PRDM15	2.55e-04	739	190	18	GO:0003682
GeneOntologyMolecularFunction	benzaldehyde dehydrogenase (NAD+) activity	ALDH3A1 ALDH3B1	2.69e-04	3	190	2	GO:0018479
GeneOntologyMolecularFunction	aldehyde dehydrogenase (NAD+) activity	ALDH3A1 ALDH3B1 ALDH3B2	3.55e-04	15	190	3	GO:0004029
GeneOntologyMolecularFunction	aldehyde dehydrogenase [NAD(P)+] activity	ALDH3A1 ALDH3B1 ALDH3B2	5.23e-04	17	190	3	GO:0004030
GeneOntologyMolecularFunction	benzaldehyde dehydrogenase [NAD(P)+] activity	ALDH3A1 ALDH3B1	5.34e-04	4	190	2	GO:0019115
Domain	Aldehyde_DH_NAD(P)	ALDH3A1 ALDH3B1 ALDH3B2	3.99e-06	4	188	3	IPR012394
Domain	HEAT	DOHH PPP4R1L NCAPD2 KPNB1 PPP2R1B	2.91e-04	58	188	5	IPR000357
Domain	IBN_N	KPNB1 RANBP17 IPO9	4.18e-04	15	188	3	PF03810
Domain	ARM-like	DOHH PPP4R1L PSMD5 NCAPD2 KPNB1 KPNA5 RANBP17 PPP2R1B IPO9 PPP6R2	4.22e-04	270	188	10	IPR011989
Domain	IBN_N	KPNB1 RANBP17 IPO9	5.10e-04	16	188	3	SM00913
Domain	Ald_DH_CS_GLU	ALDH3A1 ALDH3B1 ALDH3B2	5.10e-04	16	188	3	IPR029510
Domain	Asp/Asn-tRNA-synth_IIb	NARS1 DARS2	5.97e-04	4	188	2	IPR002312
Domain	Mterf	MTERF3 MTERF2	5.97e-04	4	188	2	SM00733
Domain	MTERF	MTERF3 MTERF2	5.97e-04	4	188	2	IPR003690
Domain	mTERF	MTERF3 MTERF2	5.97e-04	4	188	2	PF02536
Domain	Importin-beta_N	KPNB1 RANBP17 IPO9	6.15e-04	17	188	3	IPR001494
Domain	HEAT_type_2	DOHH KPNB1 PPP2R1B	6.15e-04	17	188	3	IPR021133
Domain	Ald_DH_CS_CYS	ALDH3A1 ALDH3B1 ALDH3B2	6.15e-04	17	188	3	IPR016160
Domain	ARM-type_fold	DOHH PSMD5 ITPR2 NCAPD2 UNC79 KPNB1 KPNA5 RANBP17 PPP2R1B IPO9 PPP6R2	6.67e-04	339	188	11	IPR016024
Domain	ALDEHYDE_DEHYDR_CYS	ALDH3A1 ALDH3B1 ALDH3B2	7.33e-04	18	188	3	PS00070
Domain	ALDEHYDE_DEHYDR_GLU	ALDH3A1 ALDH3B1 ALDH3B2	7.33e-04	18	188	3	PS00687
Domain	-	ALDH3A1 ALDH3B1 ALDH3B2	8.64e-04	19	188	3	3.40.605.10
Domain	Aldedh	ALDH3A1 ALDH3B1 ALDH3B2	8.64e-04	19	188	3	PF00171
Domain	Ald_DH_C	ALDH3A1 ALDH3B1 ALDH3B2	8.64e-04	19	188	3	IPR016163
Domain	Ald_DH_N	ALDH3A1 ALDH3B1 ALDH3B2	8.64e-04	19	188	3	IPR016162
Domain	Ald_DH/histidinol_DH	ALDH3A1 ALDH3B1 ALDH3B2	8.64e-04	19	188	3	IPR016161
Domain	Aldehyde_DH_dom	ALDH3A1 ALDH3B1 ALDH3B2	8.64e-04	19	188	3	IPR015590
Domain	-	ALDH3A1 ALDH3B1 ALDH3B2	8.64e-04	19	188	3	3.40.309.10
Domain	NUT	NUTM2A NUTM2B	9.88e-04	5	188	2	IPR024310
Domain	NUT_N	NUTM2A NUTM2B	9.88e-04	5	188	2	IPR024309
Domain	NUT	NUTM2A NUTM2B	9.88e-04	5	188	2	PF12881
Domain	aa-tRNA-synt_II	NARS1 DARS2	9.88e-04	5	188	2	IPR004364
Domain	tRNA-synt_2	NARS1 DARS2	9.88e-04	5	188	2	PF00152
Domain	aa-tRNA-synt_II-like	NARS1 DARS2	9.88e-04	5	188	2	IPR018150
Domain	EFG_II	EFL1 GFM1	9.88e-04	5	188	2	PF14492
Domain	HEAT	PPP4R1L NCAPD2 KPNB1 PPP2R1B	1.37e-03	48	188	4	PF02985
Domain	RIH_assoc-dom	RYR2 ITPR2	1.47e-03	6	188	2	IPR013662
Domain	EFG_C	EFL1 GFM1	1.47e-03	6	188	2	PF00679
Domain	Ins145_P3_rec	RYR2 ITPR2	1.47e-03	6	188	2	PF08709
Domain	RIH_assoc	RYR2 ITPR2	1.47e-03	6	188	2	PF08454
Domain	EFG_III-V	EFL1 GFM1	1.47e-03	6	188	2	IPR009022
Domain	RIH_dom	RYR2 ITPR2	1.47e-03	6	188	2	IPR000699
Domain	Ins145_P3_rcpt	RYR2 ITPR2	1.47e-03	6	188	2	IPR014821
Domain	Ryanodine_recept-rel	RYR2 ITPR2	1.47e-03	6	188	2	IPR015925
Domain	EFG_C	EFL1 GFM1	1.47e-03	6	188	2	SM00838
Domain	-	RYR2 ITPR2	1.47e-03	6	188	2	1.25.10.30
Domain	RYDR_ITPR	RYR2 ITPR2	1.47e-03	6	188	2	PF01365
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	SETD1B ITPR2 CEP170 MKI67 SGO2 EIF2AK3 NUP160 POLR2B HECTD4 NVL LSM12 PPP2R1B GTF3C1 PHF3 SMARCC1 ESPL1	6.19e-09	440	199	16	34244565
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	LIN54 DDB1 RECQL5 MKI67 SGO2 TIMELESS KDM5A NVL MORC2 GTF3C1 SLC4A1AP TSR1 PHF3 SMARCB1 SMARCC1 PRDM15 HDGF	9.45e-08	608	199	17	36089195
Pubmed	A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution.	NBPF12 NBPF19 NBPF3 NBPF8 NBPF20	1.10e-07	21	199	5	16079250
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	UBE4B MAP4 BCL9 MKI67 TIMELESS IQCK KDM5A REST MORC2 PALB2 GTF3C1 SLC4A1AP PHF3 CDK13 SMARCC1 CTPS1 KAT6B ESPL1 SON	1.23e-07	774	199	19	15302935
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	DDB1 AHNAK NCAPD2 UNC79 NUP160 KPNB1 REST ZNF593 IBTK GTF3C1 CDK13 SMARCB1 SMARCC1 HYDIN	6.16e-07	469	199	14	27634302
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	UBE4B NARS1 PSMD5 TIMELESS PLCG1 NUP160 EFL1 POLR2B MORC2 DARS2 LSM12 GTF3C1 SMARCB1 SMARCC1 DDX3Y CTPS1 SON	7.31e-07	704	199	17	29955894
Pubmed	Mouse aldehyde dehydrogenase ALDH3B2 is localized to lipid droplets via two C-terminal tryptophan residues and lipid modification.	ALDH3A1 ALDH3B1 ALDH3B2	7.35e-07	4	199	3	25286108
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	LIN54 DDB1 ARHGAP22 NUP160 KPNB1 POLR2B NVL MORC2 GTF3C1 TSR1 PHF3 SMARCC1 CTPS1 DCLK1 SON	1.55e-06	583	199	15	29844126
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	MAP4 NARS1 DDB1 AHNAK NCAPD2 MKI67 FKBP15 EFL1 POLR2B NVL UBXN1 MORC2 GTF3C1 TSR1 PHF3 CDK13 SMARCB1 SMARCC1 SON HDGF	1.74e-06	1014	199	20	32416067
Pubmed	Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.	PDE8A MAP4 RYR2 CEP170 KPNB1 SRA1 PPP2R1B IPO9 DCLK1	2.04e-06	195	199	9	17110338
Pubmed	Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	UBE4B PLXND1 NPHP4 ACSBG1 FKBP15 HECTD4 PPP6R2	2.11e-06	102	199	7	9734811
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	MAP4 LIN54 NUTM2A CEP170 NUTM2B AHNAK RECQL5 MKI67 SGO2 KPNB1 RARA YY2 NVL SLC4A1AP PHF3 MARF1 SMARCC1 DDX3Y SON	2.78e-06	954	199	19	36373674
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	SETD1B CASP14 UBE4B MAP4 NARS1 PSMD5 DDB1 AHNAK RECQL5 NCAPD2 MKI67 PLCG1 NUP160 KPNB1 POLR2B UBXN1 MTHFS ELP3 IPO9 GTF3C1 SMARCC1 CTPS1 SON	3.43e-06	1353	199	23	29467282
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	MAP4 DDB1 MIA2 AHNAK NCAPD2 POLR2B GTF3C1 TSR1 CDK13 SMARCC1 CTPS1 PPP6R2	3.69e-06	399	199	12	37536630
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	MAP4 DDB1 CEP170 NCAPD2 TIMELESS NUP160 KPNB1 IFT81 POLR2B ELP3 IPO9 SMARCC1 CTPS1 GFM1	4.84e-06	560	199	14	35241646
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CEP170 AHNAK RECQL5 SGO2 IFT81 POLR2B ATG2B MORC2 PALB2 LSM12 IPO9 TSR1 MRFAP1 PRDM15 HDGF	5.27e-06	645	199	15	25281560
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	SLC30A1 DDB1 STRIP2 ITPR2 CEP170 NEO1 FKBP15 POLR2B NVL LSM12 IBTK PHF3 DDHD1 CTPS1 ESPL1 GFM1	5.65e-06	733	199	16	34672954
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MAP4 NARS1 DDB1 CEP170 AHNAK NCAPD2 MKI67 NUP160 KPNB1 NVL GTF3C1 TSR1 PHF3 SMARCC1 SON	6.11e-06	653	199	15	22586326
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	MAP4 GOLM1 PLXND1 EXTL3 SLC30A1 DDB1 ITPR2 FANCA GPR180 MIA2 PTPRS TIMELESS EIF2AK3 COL12A1 GTF3C1 NETO2 LRP4 LRP6 UBAC2 PPP6R2 PBXIP1	6.13e-06	1201	199	21	35696571
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SETD1B UBE4B PLXND1 EXTL3 BCL9 NPHP4 ITPR2 FANCA PTPRS AHNAK NCAPD2 PLCG1 SZT2 HECTD4 CDK13 TMEM268 LRP4 ESPL1 ALKBH6 ARHGAP33	6.25e-06	1105	199	20	35748872
Pubmed	ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures.	REST SMARCB1 SMARCC1	6.35e-06	7	199	3	31631027
Pubmed	A "double adaptor" method for improved shotgun library construction.	NBPF12 MAP4 NARS1 ARHGAP22 ACSBG1 KDM5A POLR2B COX11 SLC1A3 CREB3L1 FAM135B IPO9 TMEM268 DCLK1	6.41e-06	574	199	14	8619474
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	MAP4 NARS1 SLC30A1 DDB1 CEP170 MIA2 AHNAK NCAPD2 KPNB1 POLR2B UBXN1 ZNF593 ELP3 SLC1A3 DARS2 SLC4A1AP TSR1 CDK13 SMARCC1 MRPL41 CTPS1 SON HDGF	7.12e-06	1415	199	23	28515276
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	NBPF12 FRMPD4 MAP4 STRIP2 GREB1L TIMELESS EIF2AK3 KPNB1 NBPF8 CACNB1 ATG2B PALB2 ASXL3	9.22e-06	513	199	13	25798074
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	BCL9 DDB1 CEP170 STOX2 PTPRD PTPRS NOS1 UNC79 KPNB1 FKBP15 CACNB1 KDM5A HECTD4 SLC1A3 PDE4DIP SMARCC1 PPP6R2 DCLK1	1.21e-05	963	199	18	28671696
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PLXND1 STOX2 ATP11B ACSBG1 NCAPD2 SZT2 HECTD4 IBTK TSR1 DDHD1 LRP4 KAT6B ESPL1	1.28e-05	529	199	13	14621295
Pubmed	A Dynamic Unfolded Protein Response Contributes to the Control of Cortical Neurogenesis.	NARS1 MKI67 EIF2AK3 ELP3	1.41e-05	26	199	4	26651292
Pubmed	Mutations in SMARCB1 and in other Coffin-Siris syndrome genes lead to various brain midline defects.	MKI67 SLC1A3 SMARCB1	2.15e-05	10	199	3	31273213
Pubmed	RNF20 controls astrocytic differentiation through epigenetic regulation of STAT3 in the developing brain.	ACSBG1 MKI67 SLC1A3	2.15e-05	10	199	3	28984873
Pubmed	Large-scale concatenation cDNA sequencing.	NBPF12 MAP4 NARS1 ACSBG1 KDM5A POLR2B COX11 SLC1A3 CREB3L1 FAM135B IPO9 TMEM268 DCLK1	2.68e-05	568	199	13	9110174
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	UBE4B DDB1 ITPR2 NCAPD2 MKI67 PPM1D POLR2B DARS2 GTF3C1 KAT6B	2.99e-05	341	199	10	32971831
Pubmed	Human aldehyde dehydrogenase genes, ALDH7 and ALDH8: genomic organization and gene structure comparison.	ALDH3B1 ALDH3B2	3.26e-05	2	199	2	9161417
Pubmed	Overexpression of MTERFD1 or MTERFD3 impairs the completion of mitochondrial DNA replication.	MTERF3 MTERF2	3.26e-05	2	199	2	20577816
Pubmed	Expression of nNOS and soluble guanylate cyclase in schizophrenic brain.	NOS1 GUCY1A2	3.26e-05	2	199	2	15094474
Pubmed	Mitochondrial calcium overload is a key determinant in heart failure.	RYR2 ITPR2	3.26e-05	2	199	2	26217001
Pubmed	Resolution of chiasmata in oocytes requires separase-mediated proteolysis.	REC8 ESPL1	3.26e-05	2	199	2	16839882
Pubmed	Structural Insights into BAF47 and BAF155 Complex Formation.	SMARCB1 SMARCC1	3.26e-05	2	199	2	28438634
Pubmed	Age-dependent susceptibility of chromosome cohesion to premature separase activation in mouse oocytes.	REC8 ESPL1	3.26e-05	2	199	2	21865557
Pubmed	Functional local crosstalk of inositol 1,4,5-trisphosphate receptor- and ryanodine receptor-dependent Ca2+ release in atrial cardiomyocytes.	RYR2 ITPR2	3.26e-05	2	199	2	28158491
Pubmed	Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling.	NOS1 XDH	3.26e-05	2	199	2	15486091
Pubmed	Three novel genes tied to mandibular prognathism in eastern Mediterranean families.	NBPF8 C1orf167	3.26e-05	2	199	2	31256822
Pubmed	A Coil-to-Helix Transition Serves as a Binding Motif for hSNF5 and BAF155 Interaction.	SMARCB1 SMARCC1	3.26e-05	2	199	2	32244797
Pubmed	The second catalytic domain of protein tyrosine phosphatase delta (PTP delta) binds to and inhibits the first catalytic domain of PTP sigma.	PTPRD PTPRS	3.26e-05	2	199	2	9566880
Pubmed	Immune-related genes LAMA2 and IL1R1 correlate with tumor sites and predict poor survival in pancreatic adenocarcinoma.	LAMA2 IL1R1	3.26e-05	2	199	2	34156282
Pubmed	Birthdating of myenteric neuron subtypes in the small intestine of the mouse.	MKI67 NOS1	3.26e-05	2	199	2	23861145
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	MAP4 PSMD5 CEP170 SACS AHNAK PLCG1 KPNA5 DARS2 PPP2R1B CDK13 SMARCB1 CTPS1	3.34e-05	498	199	12	36634849
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	MAP4 DDB1 CEP170 MKI67 SGO2 POLR2B BTBD10 NVL IBTK GTF3C1 TSR1 PHF3 CDK13 ESPL1 SON	3.52e-05	759	199	15	35915203
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	MAP4 NUTM2A NARS1 DDB1 CEP170 AHNAK MKI67 KDM5A KRT35 MORC2 LSM12 IBTK IPO9 TSR1 PHF3 CDK13 MARF1 SMARCB1 SMARCC1 DDX3Y SON	4.33e-05	1371	199	21	36244648
Pubmed	Lineage-specific gene duplication and loss in human and great ape evolution.	NBPF19 DDX12P NBPF20 LSM12 SLC4A1AP	4.87e-05	69	199	5	15252450
Pubmed	Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.	FANCA SMARCB1 SMARCC1	5.06e-05	13	199	3	11726552
Pubmed	SWI/SNF chromatin remodeling complex is required for initiation of sex-dependent differentiation in mouse germline.	MKI67 DNMT3L SMARCB1	5.06e-05	13	199	3	34912016
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	DDB1 CEP170 SACS KPNB1 FKBP15 KDM5A POLR2B HECTD4 ZNF593 GTF3C1 TSR1 SMARCB1 SMARCC1 DDX3Y MRPL41 PBXIP1 ARHGAP33 SON	5.54e-05	1082	199	18	38697112
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	ITPR2 CEP170 SRPX2 AHNAK RECQL5 TIMELESS ALDH3B2 SLC25A27 CACNB1 COL12A1 IFT81 NVL UBXN1 APIP GTF3C1 MRFAP1 PDE4DIP LRP6 ESPL1 HYDIN	5.81e-05	1293	199	20	15342556
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	MAP4 LIN54 NARS1 BCL9 CEP170 MKI67 KPNB1 RARA UBXN1 MORC2 PALB2 LSM12 GTF3C1 CDK13 SMARCB1 SMARCC1 CTPS1 HDGF	7.07e-05	1103	199	18	34189442
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	DOHH MAP4 LIN54 NARS1 AHNAK MKI67 NUP160 KPNB1 KDM5A POLR2B UBXN1 DARS2 LSM12 IPO9 TSR1 SMARCB1 SMARCC1 DDX3Y CTPS1 SON	7.54e-05	1318	199	20	30463901
Pubmed	Setd1b, encoding a histone 3 lysine 4 methyltransferase, is a maternal effect gene required for the oogenic gene expression program.	SETD1B BCL9 MKI67	7.98e-05	15	199	3	28619824
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	MAP4 DDB1 CEP170 KPNB1 POLR2B DARS2 LSM12 GTF3C1 TSR1 UBAC2 MRPL41 CTPS1 GFM1 SON	8.22e-05	725	199	14	27025967
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	LIN54 ANKRD30B RYR2 MIA2 SACS AHNAK NCAPD2 DLEC1 KPNB1 KDM5A IFT81 C2orf78 SFMBT2 PALB2 PRX GTF3C1 GUCY1A2 CDK13 MARF1 SMARCC1 IL1R1	8.84e-05	1442	199	21	35575683
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	ANKRD30B DDB1 NUP160 KPNB1 POLR2B MTERF3 C1orf167 UBXN1 ELP3 DARS2 LSM12 PPP2R1B IPO9 GTF3C1 TSR1 SMARCB1 DDX3Y MRPL41 CTPS1 PPP6R2	8.97e-05	1335	199	20	29229926
Pubmed	Retinoic acid-dependent activation of the polycystic kidney disease-1 (PKD1) promoter.	RXRB RARA	9.74e-05	3	199	2	18922886
Pubmed	Expression and subcellular distribution of imp13 are regulated in brain development.	KPNB1 IPO9	9.74e-05	3	199	2	23605716
Pubmed	Calcium-dependent N-cadherin up-regulation mediates reactive astrogliosis and neuroprotection after brain injury.	ITPR2 SLC1A3	9.74e-05	3	199	2	23798419
Pubmed	LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses.	PTPRD PTPRS	9.74e-05	3	199	2	31985401
Pubmed	Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formation.	PTPRD PTPRS	9.74e-05	3	199	2	20139422
Pubmed	Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR.	PTPRD PTPRS	9.74e-05	3	199	2	33656439
Pubmed	Combined pituitary hormone deficiency due to the F135C human Pit-1 (pituitary-specific factor 1) gene mutation: functional and structural correlates.	POU1F1 SLC22A2	9.74e-05	3	199	2	11222742
Pubmed	Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes.	RYR2 NOS1	9.74e-05	3	199	2	18077344
Pubmed	Importin α-importin β complex mediated nuclear translocation of insulin-like growth factor binding protein-5.	KPNB1 KPNA5	9.74e-05	3	199	2	28835592
Pubmed	Real-time analysis of molecular interaction of retinoid receptors and receptor-interacting protein 140 (RIP140).	RXRB RARA	9.74e-05	3	199	2	12403842
Pubmed	Interaction with RXR is necessary for NPM-RAR-induced myeloid differentiation blockade.	RXRB RARA	9.74e-05	3	199	2	24183235
Pubmed	Self-regulated alternative splicing at the AHNAK locus.	AHNAK PRX	9.74e-05	3	199	2	21940993
Pubmed	The inhibitory neurotransmitter GABA evokes long-lasting Ca(2+) oscillations in cortical astrocytes.	ITPR2 SLC1A3	9.74e-05	3	199	2	26496414
Pubmed	Methylation-mediated silencing of PTPRD induces pulmonary hypertension by promoting pulmonary arterial smooth muscle cell migration via the PDGFRB/PLCγ1 axis.	PTPRD PLCG1	9.74e-05	3	199	2	35848503
Pubmed	The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney.	NUTM2B NUTM2E	9.74e-05	3	199	2	26542179
Pubmed	Interaction between protein phosphatase 2A and members of the importin beta superfamily.	PPP2R1B IPO9	9.74e-05	3	199	2	12670497
Pubmed	Characterization of receptor-interacting protein 140 in retinoid receptor activities.	RXRB RARA	9.74e-05	3	199	2	10531331
Pubmed	The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.	NUTM2A NUTM2B	9.74e-05	3	199	2	22456610
Pubmed	Reactive astrocyte-driven epileptogenesis is induced by microglia initially activated following status epilepticus.	ITPR2 SLC1A3	9.74e-05	3	199	2	33830944
Pubmed	In vitro and in vivo effects of suppressor of cytokine signalling 7 knockdown in breast cancer: the influence on cellular response to hepatocyte growth factor.	SOCS7 PLCG1	9.74e-05	3	199	2	25162020
Pubmed	Role of cleavage by separase of the Rec8 kleisin subunit of cohesin during mammalian meiosis I.	REC8 ESPL1	9.74e-05	3	199	2	19625504
Pubmed	Developmental expression of the cell adhesion molecule-like protein tyrosine phosphatases LAR, RPTPdelta and RPTPsigma in the mouse.	PTPRD PTPRS	9.74e-05	3	199	2	9784606
Pubmed	Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion.	PTPRD PTPRS	9.74e-05	3	199	2	25394468
Pubmed	A family of putative transcription termination factors shared amongst metazoans and plants.	MTERF3 MTERF2	9.74e-05	3	199	2	16193327
Pubmed	Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler.	SMARCB1 SMARCC1	9.74e-05	3	199	2	33931740
Pubmed	MicroRNA-202 safeguards meiotic progression by preventing premature SEPARASE-mediated REC8 cleavage.	REC8 ESPL1	9.74e-05	3	199	2	35712867
Pubmed	BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell-cycle arrest.	SMARCB1 SMARCC1	9.74e-05	3	199	2	21520050
Pubmed	Docking motif-guided mapping of the interactome of protein phosphatase-1.	SACS MKI67 FKBP15 MARF1 HYDIN	9.90e-05	80	199	5	19389623
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	UBE4B MAP4 NARS1 PSMD5 DPP8 DDB1 AHNAK NCAPD2 TIMELESS PLCG1 NUP160 KPNB1 EFL1 POLR2B UBXN1 ELP3 PPP2R1B IPO9 TSR1 CTPS1 HDGF	1.00e-04	1455	199	21	22863883
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	DDB1 MKI67 NUP160 KPNB1 HECTD4 PALB2 GTF3C1 SON	1.04e-04	250	199	8	33536335
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	FANCA FREM2 TIMELESS MORC2 IBTK GTF3C1 TSR1 CDK13 DDHD1 MARF1 SMARCC1 PPP6R2 PBXIP1	1.05e-04	650	199	13	38777146
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	FRMPD4 MAP4 SLC30A1 RYR2 CEP170 NEO1 ACSBG1 NOS1 FKBP15 CACNB1 STXBP5L ATG2B SLC1A3 LSM12 PDE4DIP GFM1 PPP6R2 DCLK1	1.06e-04	1139	199	18	36417873
Pubmed	Identification of a polymorphic, neuron-specific chromatin remodeling complex.	MKI67 SMARCB1 SMARCC1	1.18e-04	17	199	3	12368262
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	LIN54 DDB1 CEP170 STOX2 AHNAK MKI67 SGO2 TIMELESS GNAT2 NUP160 KPNB1 XDH PPP2R1B GTF3C1 TSR1 SMARCB1 SMARCC1 ESPL1	1.26e-04	1155	199	18	20360068
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	DDB1 STRIP2 PRR14 MKI67 KPNB1 HTR2C PPM1D ELP3 PPP2R1B SLC4A1AP CTPS1 PPP6R2	1.26e-04	573	199	12	28330616
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SETD1B FRMPD4 UBE4B CAMTA2 STRIP2 FKBP15 PHF24 PHF3 PDE4DIP SON	1.30e-04	407	199	10	12693553
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	LIN54 RXRB NCAPD2 EIF2AK3 NUP160 KPNA5 KDM5A IFT81 MORC2 ELP3 DARS2 GTF3C1 SMARCB1 SMARCC1 PRDM15	1.36e-04	857	199	15	25609649
Pubmed	Tagging genes with cassette-exchange sites.	SOCS7 MKI67 POLR2B REST ELP3 RANBP17 TSR1 SMARCC1 KAT6B	1.45e-04	335	199	9	15741177
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	DDB1 RYR2 KPNB1 DARS2 CDK13 MARF1 DDX3Y	1.48e-04	197	199	7	20811636
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	UBE4B NARS1 PSMD5 EXTL3 PTPRD MIA2 SACS PLCG1 KPNB1 KDM5A IFT81 HECTD4 MRFAP1 PDE4DIP LRRCC1 LRP4 ALKBH6 PBXIP1 DCLK1	1.60e-04	1285	199	19	35914814
Pubmed	Deletion of the epidermis derived laminin γ1 chain leads to defects in the regulation of late hair morphogenesis.	MKI67 KRT35 LAMA2	1.67e-04	19	199	3	27234308
Interaction	SIRT6 interactions	SETD1B DDB1 ITPR2 FANCA CEP170 ARHGAP22 NCAPD2 MKI67 SGO2 EIF2AK3 NUP160 POLR2B HECTD4 NVL LSM12 PPP2R1B GTF3C1 PHF3 SMARCC1 ESPL1	3.49e-06	628	196	20	int:SIRT6
GeneFamily	Neuroblastoma breakpoint family	NBPF12 NBPF19 NBPF3 NBPF8 NBPF20	5.60e-07	23	131	5	662
GeneFamily	Armadillo repeat containing\|Importins	KPNB1 KPNA5 IPO9	2.80e-04	18	131	3	596
GeneFamily	Aldehyde dehydrogenases	ALDH3A1 ALDH3B1 ALDH3B2	3.31e-04	19	131	3	398
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#1_top-relative-expression-ranked_200	EXTL3 PTPRD NCAPD2 LSM12 MTERF2	1.33e-06	22	192	5	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_200_k1
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000	GOLM1 BCL9 RYR2 ITPR2 GREB1L BNC1 FREM2 NEO1 PTPRS NYNRIN NOS1 COL12A1 IFT81 MTHFS CREB3L1 GUCY1A2 ASXL3 IL1R1 KAT6B DCLK1	3.83e-05	797	192	20	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 RYR2 FREM2 PTPRD UNC79 COL12A1 DNAH10 STXBP5L ASXL3 HYDIN	1.12e-08	184	199	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 RYR2 FREM2 PTPRD UNC79 COL12A1 DNAH10 STXBP5L ASXL3 HYDIN	1.12e-08	184	199	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 RYR2 FREM2 PTPRD UNC79 COL12A1 DNAH10 STXBP5L ASXL3 HYDIN	1.12e-08	184	199	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	control-Lymphoid-CTL\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	NARS1 ATP11B AHNAK PLCG1 REST SFMBT2 TXNIP CDK13 DDHD1 SON	1.77e-08	193	199	10	89d407a88b5956559a589425b89b3eb8dc78e1dd
ToppCell	droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOCS7 ATP11B MKI67 SGO2 PLCG1 CACNB1 PALB2 SHROOM1 PRDM15	6.62e-08	167	199	9	bad33497ceeab968a7eb8a48b921c6f936390743
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MASP1 RYR2 SCN2B COL12A1 LAMA2 LRP4 PNPLA7 DEPDC7	1.62e-06	181	199	8	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	ASK454-Epithelial\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	PRMT8 SOCS7 HEBP1 ALDH3B1 IQCK COL12A1 C11orf16 HYDIN	1.68e-06	182	199	8	ab15316cff989b61ff397a866d7ca8b49c13e981
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	FANCA MKI67 KPNB1 KDM5A IPO9 ESPL1 SON HDGF	2.51e-06	192	199	8	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	EXTL3 FREM2 ACSBG1 SACS PTPRS LAMA2 CREB3L1 NETO2	2.71e-06	194	199	8	8b81f039f5b25d35a4d5a41b27d4d9360ba22f15
ToppCell	(05)_Ciliated\|World / shred by cell type and Timepoint	CATIP NME5 DLEC1 ALDH3B1 DNAH10 C11orf16 AK8 HYDIN	3.04e-06	197	199	8	fee3cd16af8eea697cd64e8f64af505aaa2ac4b0
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	LIN54 SRA1 MTHFS SLC4A1AP PHF3 GFM1 HDGF	5.85e-06	153	199	7	553dff9688a1996d8f4ba16e60c683593d781389
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ITPR2 ACSBG1 LAMA2 SLC1A3 PNPLA7 PBXIP1 SON	5.85e-06	153	199	7	95b28c5bd10ffb74c0993ebd565038b9818e4bd2
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	LIN54 SRA1 MTHFS SLC4A1AP PHF3 GFM1 HDGF	5.85e-06	153	199	7	88ca2d2c2ab19fbee13e18951b993ee05dd30f67
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte-Astro\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ITPR2 ACSBG1 LAMA2 SLC1A3 PNPLA7 PBXIP1 SON	5.85e-06	153	199	7	b09f8def40a1ea56722f3398f61a036667b61cd9
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ITPR2 ACSBG1 LAMA2 SLC1A3 PNPLA7 PBXIP1 SON	5.85e-06	153	199	7	3ab9d55b3db51715c1d61eca142384195ce4b54f
ToppCell	droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCAPD2 MKI67 SGO2 TIMELESS LRRCC1 DDX3Y DEPDC7	9.59e-06	165	199	7	96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NARS1 SLC30A1 FANCA MKI67 SGO2 CACNB1 DNAH10	1.31e-05	173	199	7	506efcaa5afd6ed5e565c4c4def6a4505fea97c5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FANCA NCAPD2 MKI67 SGO2 TIMELESS ESPL1 ARHGAP33	1.31e-05	173	199	7	a25459b8140b0dbcb73e3b4cc1407b679229f25c
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PGAP6 STRIP2 FANCA ARHGAP22 SCN2B DLEC1 PDE4DIP	1.35e-05	174	199	7	7be0c6248e77f2d0260b852b01e17892f7828f1b
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL9 STRIP2 CABP4 SCN2B MTHFS SFMBT2 GUCY1A2	1.41e-05	175	199	7	91cb819a1786020713b7e64480de0545380daae9
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MASP1 SRPX2 ACSBG1 AHNAK SLC1A3 TXNIP LRP4	1.51e-05	177	199	7	191c14e0ef162536028b841f3759aaddef59b49d
ToppCell	356C-Fibroblasts-Fibroblast-G\|356C / Donor, Lineage, Cell class and subclass (all cells)	RYR2 SRPX2 PTPRD PTPRS PCDHB12 LEFTY1 DEPDC7	1.51e-05	177	199	7	8220cc2fc0ee8764a67a3be51d75248be2453040
ToppCell	356C-Fibroblasts-Fibroblast-G-\|356C / Donor, Lineage, Cell class and subclass (all cells)	RYR2 SRPX2 PTPRD PTPRS PCDHB12 LEFTY1 DEPDC7	1.51e-05	177	199	7	7617270f49cd6b7ba66db72d20560cee985012b2
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	PLXND1 STRIP2 FANCA GREB1L ALDH3B2 KASH5	1.67e-05	120	199	6	a6d0406a174d46ce06b41280292931954af88a59
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	FANCA ACSBG1 RECQL5 NCAPD2 MKI67 SRA1 ZNF593	1.75e-05	181	199	7	c18e5a3f5d99043fa3cb33e2ac33fa98cd15d3db
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CATIP NME5 DLEC1 DNAH10 C11orf16 AK8 HYDIN	1.81e-05	182	199	7	000eca5baa6eb2335a1e6d76a13fff5382b0e150
ToppCell	P07-Epithelial-airway_epithelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NME5 ALDH3B1 DNAH10 C11orf16 AK8 KASH5 HYDIN	1.94e-05	184	199	7	a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2
ToppCell	P07-Epithelial-airway_epithelial_cell-club_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NME5 ALDH3B1 DNAH10 C11orf16 AK8 KASH5 HYDIN	1.94e-05	184	199	7	ab469b9e06212462cbe2e4db8775c6778db855e6
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	MAP4 RYR2 GREB1L NRAP LAMA2 SLC1A3 PDE4DIP	1.94e-05	184	199	7	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	Ciliated-cil-2\|World / Class top	CATIP NME5 ALDH3B1 DNAH10 C11orf16 AK8 HYDIN	2.16e-05	187	199	7	e2e58ba039b5355c03c3b448e750aa37b0ea6913
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CATIP PRMT8 NME5 DLEC1 DNAH10 C11orf16 AK8	2.16e-05	187	199	7	9e10ed56090d82589bc457788282f664b70ace4b
ToppCell	Ciliated\|World / Class top	CATIP NME5 ALDH3B1 DNAH10 C11orf16 AK8 HYDIN	2.23e-05	188	199	7	cc9178361360b5800f96516ed6a65089c144b1ce
ToppCell	facs-Thymus-Flowthrough-3m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP4 SLC6A19 PLXND1 CEP170 SCN2B KDM5A TXNIP	2.23e-05	188	199	7	59b71462338a7efbacf46577cb07e9db3363afee
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRMT8 NME5 DLEC1 DNAH10 C11orf16 AK8 HYDIN	2.31e-05	189	199	7	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	Epithelial-D_(Ciliated)\|World / shred on cell class and cell subclass (v4)	CATIP NME5 ALDH3B1 DNAH10 IFT81 C11orf16 HYDIN	2.31e-05	189	199	7	0bf560b595c7a8450a46bc821b742b67965bd9f9
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	NEO1 SRPX2 PTPRD PTPRS XDH SLC1A3 LRP4	2.47e-05	191	199	7	3379d145d34f89150f7b06d1340022cfc6b4a6ce
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	NEO1 SRPX2 PTPRD PTPRS XDH APIP LRP4	2.47e-05	191	199	7	e7c605b56934d1383237c1f946dbccef25d91368
ToppCell	droplet-Tongue-nan-3m-Epithelial-suprabasal_interpapillary\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A19 ITPR2 ACSBG1 AHNAK ALDH3A1 ALDH3B2 CREB3L1	2.47e-05	191	199	7	abdd93b2313e635f75a750d051a6a01ddc4e2df9
ToppCell	Ciliated-cil-3\|World / Class top	FANCA NME5 DLEC1 ALDH3B1 DNAH10 C11orf16 HYDIN	2.55e-05	192	199	7	4989ebb8812b8af1870599acd932849122c05a29
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1\|TCGA-Endometrium / Sample_Type by Project: Shred V9	EXTL3 STRIP2 FANCA FREM2 KPNB1 EFL1 LRP4	2.64e-05	193	199	7	c2673d86f7d7b849788036032a93a6d136a70040
ToppCell	Control_saline-Epithelial_airway-airway_epithelial-Ciliated\|Control_saline / Treatment groups by lineage, cell group, cell type	CATIP PRMT8 DLEC1 DNAH10 C11orf16 AK8 HYDIN	2.82e-05	195	199	7	60067b5359174f0d1a8b5748bfc0690762e9e740
ToppCell	LPS-antiTNF-Unknown-Endothelial-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RYR2 MKI67 SGO2 TSSK3 NRAP DNAH10	2.86e-05	132	199	6	02491930097b75aaeedab9e8200711b0dc610944
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG\|World / Primary Cells by Cluster	NBPF19 AHNAK MKI67 REST SLC1A3 CREB3L1 LRP4	3.01e-05	197	199	7	61749ccafeb938c310cff1de5ff924a1c794325a
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG-25\|World / Primary Cells by Cluster	NBPF19 AHNAK MKI67 REST SLC1A3 CREB3L1 LRP4	3.01e-05	197	199	7	9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Gpr139\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GOLM1 STRIP2 AHNAK ALDH3A1 CREB3L1 GPR139	3.11e-05	134	199	6	917b8951dd4c870b6b92f2e73e02dac884330c30
ToppCell	distal-Epithelial-Ciliated-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CATIP NME5 DLEC1 DNAH10 C11orf16 AK8 HYDIN	3.21e-05	199	199	7	6ce0df4a6f4d9353919e26ffab97c9ec89911da6
ToppCell	Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	NYNRIN RECQL5 COL12A1 MTERF3 LAMA2 MORC2 DARS2	3.31e-05	200	199	7	5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317
ToppCell	facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP22 STOX2 SCN2B AK8 LEFTY1 TMEM268	7.53e-05	157	199	6	5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446
ToppCell	facs-Marrow-KLS-18m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP22 STOX2 SCN2B AK8 LEFTY1 TMEM268	7.53e-05	157	199	6	ad9c9b7dfeee3ae46e7e593c51a0407df12195b4
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GREB1L FREM2 NME5 IQCK COL12A1 DNAH10	7.80e-05	158	199	6	f296ca24fdedc33f1d24b79e7660763114ce7fa3
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GREB1L FREM2 NME5 IQCK COL12A1 DNAH10	7.80e-05	158	199	6	8c7108f2c40d97a317762ba0b8eca76542b2ebaf
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	PDE8A MAP4 AHNAK SZT2 SFMBT2 PBXIP1	8.96e-05	162	199	6	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	LPS-antiTNF-Epithelial_airway-Mes-Epi-like\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPR180 MKI67 SGO2 TIMELESS ESPL1 ARHGAP33	9.58e-05	164	199	6	4307b002fb41ddfc7ab8a6bca66a60942c250052
ToppCell	LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPR180 MKI67 SGO2 TIMELESS ESPL1 ARHGAP33	9.58e-05	164	199	6	1d84aa5b925f502ee9c5fa39714490f613a58028
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	SETD1B TSSK3 SZT2 HECTD4 SMARCC1 SON	1.02e-04	166	199	6	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	COVID-19-Heart-CM_+_Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RYR2 GREB1L NRAP LAMA2 SLC1A3 PDE4DIP	1.17e-04	170	199	6	3f15242a1d3e4e9871d9170b2ef05842fb609c29
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FANCA MKI67 COL12A1 LAMA2 GUCY1A2 DCLK1	1.20e-04	171	199	6	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FANCA MKI67 COL12A1 LAMA2 GUCY1A2 DCLK1	1.20e-04	171	199	6	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LIN54 PTPRD NCAPD2 MKI67 SGO2 DEPDC7	1.24e-04	172	199	6	29c8510f26527d487d0fc3543102d067cdb281a6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FANCA NCAPD2 MKI67 SGO2 ESPL1 ARHGAP33	1.32e-04	174	199	6	dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TDRKH GUCY1A2 DEPDC7 PPP6R2 PRDM15 ARHGAP33	1.32e-04	174	199	6	6c36d607c48267a75ab4da6fb2fe3f931d1b3b52
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SRPX2 NCAPD2 MKI67 SGO2 COL12A1 ESPL1	1.37e-04	175	199	6	a154b28b0b2180652d51d4c7d804b3b81b35899e
ToppCell	droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PGAP6 ARHGAP22 SCN2B NCAPD2 MKI67 SGO2	1.37e-04	175	199	6	73f25bd54309aed1480ddc44bdab518b17e71f92
ToppCell	droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXND1 ARHGAP22 CACNB1 PHF24 DARS2 SLC4A1AP	1.41e-04	176	199	6	24b2e94ee5defcefb64a1f2447a2cc71b015b0fd
ToppCell	3'-Adult-Appendix-Epithelial-mature_enterocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANKRD30B SGO2 UNC79 SLC25A27 COX11 ASXL3	1.41e-04	176	199	6	30adf8f1638c6244586f8101c2590bb964dfae00
ToppCell	3'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANKRD30B SGO2 UNC79 SLC25A27 COX11 ASXL3	1.41e-04	176	199	6	23fa02d4c39e0b8faa1658116d50b6233a952ccc
ToppCell	primary_visual_cortex-Non-neuronal\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ITPR2 ACSBG1 LAMA2 SLC1A3 TXNIP PBXIP1	1.41e-04	176	199	6	2c92f3f55d668cfe80051b5128160a6dc3aec4e8
ToppCell	droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BCL9 STRIP2 PTPRS SCN2B MTHFS GUCY1A2	1.45e-04	177	199	6	4672cc75225a4a23b298afa8ce439628262519db
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NCAPD2 MKI67 SGO2 PALB2 FER1L4 DCLK1	1.45e-04	177	199	6	4197cf2b1e743230c821f422836fa5991b155a52
ToppCell	droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLXND1 ARHGAP22 CACNB1 PHF24 DARS2 SLC4A1AP	1.45e-04	177	199	6	f360f7099570d248531897b96e0de282e58f59e9
ToppCell	droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CATIP NPHP4 NME5 C11orf16 KASH5 HYDIN	1.45e-04	177	199	6	d947ba38db1772fc5fdcdc211f7511c4aa699dee
ToppCell	droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CATIP NPHP4 NME5 C11orf16 KASH5 HYDIN	1.45e-04	177	199	6	d5640f0097878f0dac671e51dc51310278bb2682
ToppCell	Dividing_Macrophages-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	NCAPD2 MKI67 SGO2 TIMELESS ESPL1 ARHGAP33	1.50e-04	178	199	6	1893fadac2ec3d5de0a641e57b7b2f962012a9ba
ToppCell	facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NME5 DLEC1 DNAH10 C11orf16 AK8 HYDIN	1.55e-04	179	199	6	d4efbc34f52136039b96451fd0b0a0ad164197c6
ToppCell	facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NME5 DLEC1 DNAH10 C11orf16 AK8 HYDIN	1.55e-04	179	199	6	8a66d197a2f55d763ff7ef0bec89ee96f59c3937
ToppCell	droplet-Spleen-nan-3m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCAPD2 MKI67 SGO2 TIMELESS DARS2 SLC22A2	1.55e-04	179	199	6	54621d2b3a66e62aa76b7e444118878ed97c1e02
ToppCell	frontal_cortex-Non-neuronal\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ITPR2 ACSBG1 SLC1A3 TXNIP PBXIP1 SON	1.55e-04	179	199	6	ef01478bd03eb00f0ff2b6a8ae9244687c5f85aa
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NME5 ALDH3A1 DNAH10 C11orf16 SLC22A2 HYDIN	1.59e-04	180	199	6	adf5db5bfa9a38b1227ab0beccd8d6f3eea67ac0
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	CATIP CAMTA2 PLXND1 BCL9 PLCG1 FBXO34	1.59e-04	180	199	6	81d60f0fa9e3b5bfcec85139a0a49e9130145f0e
ToppCell	P15-Endothelial-proliferative_endothelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NPHP4 FANCA NCAPD2 MKI67 SGO2 HDGF	1.64e-04	181	199	6	0c5bc1660b8fc1e905ab4230202862de5be46ebd
ToppCell	normal_Lung-Fibroblasts-Pericytes\|normal_Lung / Location, Cell class and cell subclass	MASP1 RYR2 SRPX2 COL12A1 PCDHB12 GUCY1A2	1.64e-04	181	199	6	f74941e49950027360d71ea3b205fc20c6929766
ToppCell	P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NPHP4 FANCA NCAPD2 MKI67 SGO2 HDGF	1.64e-04	181	199	6	f83565f09dd971c5cad2704a4a86bca0accd955e
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MKI67 SGO2 ALDH3A1 CREB3L1 FER1L4 ESPL1	1.64e-04	181	199	6	c26d3cbbc592299786d79d1b15fc6bead2aafb9a
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RYR2 GREB1L NRAP LAMA2 SLC1A3 PDE4DIP	1.64e-04	181	199	6	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-keratinocyte_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCAPD2 MKI67 SGO2 STXBP5L NETO2 ESPL1	1.69e-04	182	199	6	0fc45214f0b0766f69be6eff69cc4bec574023aa
ToppCell	Adult-Epithelial-basal_cell\|Adult / Lineage, Cell type, age group and donor	FRMPD4 ALDH3A1 HTR2C STXBP5L C2orf78 ASXL3	1.74e-04	183	199	6	00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81
ToppCell	facs-Lung-EPCAM-24m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CATIP NME5 DNAH10 C11orf16 AK8 HYDIN	1.79e-04	184	199	6	afb11ab301ef9801333dbb53ccff4bd0d44f1677
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SRPX2 COL12A1 PHF24 LAMA2 GUCY1A2 DCLK1	1.79e-04	184	199	6	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	facs-Lung-EPCAM-24m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CATIP NME5 DNAH10 C11orf16 AK8 HYDIN	1.79e-04	184	199	6	a411c0bcb283534a1c15f22473c46b7d87e01294
ToppCell	E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CATIP NME5 DLEC1 C11orf16 AK8 HYDIN	1.79e-04	184	199	6	797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b
ToppCell	Control-immature_Neutrophil-\|Control / Disease condition and Cell class	NCAPD2 MKI67 SGO2 DNAH10 PPP2R1B IL1R1	1.79e-04	184	199	6	c4e8ba82a6aa76c46f05a71d5f1c7926555318cf
ToppCell	Control-immature_Neutrophil\|Control / Disease condition and Cell class	NCAPD2 MKI67 SGO2 DNAH10 PPP2R1B IL1R1	1.79e-04	184	199	6	2fdae5c6b3eb2232881d933a8c1061fda3623016
ToppCell	E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CATIP NME5 DLEC1 C11orf16 AK8 HYDIN	1.79e-04	184	199	6	77d5b60a20b277f589b18f7a131142a7ef2dac17
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SRPX2 AHNAK SLC1A3 TXNIP LRP4 PBXIP1	1.79e-04	184	199	6	22c18964818fc9c8f18051f836d718937b0d8d12
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RYR2 GREB1L NRAP LAMA2 SLC1A3 PDE4DIP	1.85e-04	185	199	6	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CATIP NPHP4 FREM2 DNAH10 C11orf16 HYDIN	1.85e-04	185	199	6	05bc89a566b0db90ae06506e067190a4739a0974
ToppCell	facs-Thymus-Flowthrough-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP4 SLC6A19 PLXND1 SCN2B KDM5A TXNIP	1.85e-04	185	199	6	dc59b8dc459a3c444c9634a0d438cbef54c40036
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SRPX2 PTPRD EFL1 ELP3 TSR1 CTPS1	1.85e-04	185	199	6	9878392d79734ab5bb977d7f4f5e2e079b9a5353
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FANCA NCAPD2 MKI67 SGO2 ESPL1 ARHGAP33	1.85e-04	185	199	6	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MASP1 FREM2 ACSBG1 AHNAK SLC1A3 LRP4	1.90e-04	186	199	6	73cf266aeecd3cc15e8cb6094588a393bca8fbe6
Drug	Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A	NPHP4 GREB1L RECQL5 NME5 TIMELESS ALDH3A1 NOS1 TDRKH LAMA2 XDH PRELID3A ARHGAP33	1.41e-07	196	196	12	3816_DN
Drug	Merbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A	UBE4B NUP160 RARA UBXN1 ELP3 PHF3 CDK13 PDE4DIP SMARCC1 PPP6R2 PBXIP1	1.30e-06	199	196	11	7398_DN
Drug	Thyroxine (L) [51-48-9]; Up 200; 5.2uM; MCF7; HT_HG-U133A	RYR2 RECQL5 NME5 TIMELESS ALDH3A1 NOS1 REC8 TDRKH SZT2 TSR1 ARHGAP33	1.30e-06	199	196	11	3249_UP
Drug	Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A	CAMTA2 NYNRIN PLCG1 NOS1 REST IPO9 PRELID3A CDK13 PPP6R2 PBXIP1	7.76e-06	195	196	10	2317_DN
Drug	Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; PC3; HT_HG-U133A	SCN2B NME5 PLCG1 ALDH3B2 TDRKH CACNB1 SZT2 POU1F1 CDK13 PDE4DIP	7.76e-06	195	196	10	4232_UP
Drug	Gemfibrozil [25812-30-0]; Down 200; 16uM; MCF7; HT_HG-U133A	MAP4 CAMTA2 PTPRS PLCG1 ALDH3B2 KDM5A REST CDK13 PBXIP1 ARHGAP33	8.49e-06	197	196	10	2277_DN
Drug	Metoclopramide monohydrochloride [7232-21-5]; Up 200; 11.8uM; HL60; HT_HG-U133A	MAP4 EXTL3 PLCG1 ALDH3A1 NOS1 IQCK REST SMARCC1 KAT6B PBXIP1	8.49e-06	197	196	10	2353_UP
Drug	Bicuculline (+) [485-49-4]; Down 200; 10.8uM; HL60; HT_HG-U133A	MAP4 ITPR2 RECQL5 PLCG1 CACNB1 RARA PHF3 PDE4DIP LRP6 ARHGAP33	8.87e-06	198	196	10	2139_DN
Drug	Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A	MAP4 CAMTA2 PTPRS FGD1 ALDH3B2 RARA UBXN1 PRELID3A KAT6B PPP6R2	8.87e-06	198	196	10	4979_DN
Drug	Propranolol hydrochloride [318-98-9]; Down 200; 13.6uM; MCF7; HT_HG-U133A	CALML5 AHNAK NME5 FGD1 TIMELESS RARA UBXN1 CDK13 PDE4DIP PBXIP1	8.87e-06	198	196	10	3396_DN
Drug	Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; HL60; HT_HG-U133A	MAP4 ALDH3B2 PCDHB1 KPNA5 IFT81 C11orf16 SLC1A3 PPP2R1B GUCY1A2 PDE4DIP	8.87e-06	198	196	10	2453_UP
Drug	Pepstatin A [26305-03-3]; Up 200; 5.8uM; PC3; HT_HG-U133A	DOHH PRMT8 ITPR2 FGD1 LAMA2 RANBP17 PRELID3A PDE4DIP LRP4 DDX3Y	9.27e-06	199	196	10	4206_UP
Drug	Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; HL60; HT_HG-U133A	RYR2 AHNAK ALDH3A1 REC8 RARA STXBP5L LAMA2 C11orf16 LRP6 A4GNT	9.69e-06	200	196	10	2575_UP
Drug	4-hydroxy-3-methoxymandelaldehyde	ALDH3A1 ALDH3B1 ALDH3B2	1.23e-05	6	196	3	CID000440729
Drug	homovanillin	ALDH3A1 ALDH3B1 ALDH3B2	3.41e-05	8	196	3	CID000151276
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A	DOHH UBE4B MAP4 MKI67 KDM5A PPP2R1B LRP6 IL1R1 ESPL1	3.67e-05	187	196	9	4989_DN
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A	MAP4 PLXND1 MIA2 NME5 IFT81 REST TXNIP PHF3 SMARCC1	4.15e-05	190	196	9	4306_DN
Drug	Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; PC3; HT_HG-U133A	DOHH FANCA SRPX2 NUP160 KPNA5 TXNIP CDK13 LRP6 PBXIP1	4.15e-05	190	196	9	6718_DN
Drug	Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A	DOHH MAP4 FKBP15 XDH REST PHF3 SMARCC1 LRP6 KAT6B	4.51e-05	192	196	9	4104_DN
Drug	Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A	DOHH CAMTA2 FANCA PLCG1 NOS1 NUP160 RARA TSR1 PDE4DIP	5.08e-05	195	196	9	4360_DN
Drug	Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A	UBE4B RYR2 RECQL5 TIMELESS NOS1 RARA IFT81 CDK13 PDE4DIP	5.08e-05	195	196	9	2311_DN
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	PLXND1 BCL9 AHNAK PLCG1 IFT81 UBXN1 TXNIP MARF1 PBXIP1	5.08e-05	195	196	9	1045_UP
Drug	Nomegestrol acetate [58652-20-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A	MAP4 EXTL3 RYR2 FGD1 TDRKH RARA KDM5A REST ARHGAP33	5.29e-05	196	196	9	5461_DN
Drug	Ascorbic acid [50-81-7]; Up 200; 22.4uM; MCF7; HT_HG-U133A	MAP4 SRPX2 FGD1 ALDH3A1 HTR2C XDH UBXN1 PRELID3A ARHGAP33	5.29e-05	196	196	9	3225_UP
Drug	Practolol [6673-35-4]; Up 200; 15uM; MCF7; HT_HG-U133A	MASP1 ACSBG1 RECQL5 NME5 RARA UBXN1 C11orf16 PRELID3A PBXIP1	5.29e-05	196	196	9	3204_UP
Drug	Tinidazole [19387-91-8]; Down 200; 16.2uM; PC3; HT_HG-U133A	MAP4 MIA2 NME5 PLCG1 TDRKH RARA IFT81 UBXN1 IL1R1	5.29e-05	196	196	9	4548_DN
Drug	Methylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; PC3; HT_HG-U133A	DOHH ITPR2 ACSBG1 REC8 CREB3L1 PRELID3A LRP4 PBXIP1 ARHGAP33	5.29e-05	196	196	9	3994_UP
Drug	Ergocryptine-alpha [511-09-1]; Down 200; 7uM; MCF7; HT_HG-U133A	DOHH CALML5 FANCA RECQL5 NME5 TIMELESS TDRKH MORC2 IPO9	5.29e-05	196	196	9	4374_DN
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A	DOHH ITPR2 PTPRS PLCG1 SZT2 UBXN1 RANBP17 GUCY1A2 IL1R1	5.50e-05	197	196	9	4764_DN
Drug	Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; MCF7; HT_HG-U133A	MAP4 EXTL3 NPHP4 RYR2 PTPRS PLCG1 FKBP15 LRP6 IL1R1	5.50e-05	197	196	9	2301_DN
Drug	alpha-estradiol; Up 200; 0.01uM; PC3; HT_HG-U133A	ABCA3 PLXND1 EXTL3 FANCA ARHGAP22 MIA2 REST PPP2R1B PHF3	5.50e-05	197	196	9	1210_UP
Drug	Acenocoumarol [152-72-7]; Up 200; 11.4uM; HL60; HG-U133A	PGAP6 FANCA KPNB1 NVL PALB2 GTF3C1 SMARCC1 KAT6B PBXIP1	5.50e-05	197	196	9	1394_UP
Drug	Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; HL60; HT_HG-U133A	SRPX2 AHNAK TIMELESS REC8 CACNB1 GUCY1A2 CDK13 PDE4DIP PBXIP1	5.50e-05	197	196	9	2188_UP
Drug	Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; HL60; HT_HG-U133A	DOHH EXTL3 FGD1 PLCG1 NOS1 REC8 RARA C11orf16 DDX3Y	5.72e-05	198	196	9	6146_UP
Drug	Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A	PRMT8 FRMPD4 AHNAK RECQL5 CACNB1 STXBP5L XDH PPP2R1B IL1R1	5.72e-05	198	196	9	2269_UP
Drug	Pridinol methanesulfonate salt [6856-31-1]; Up 200; 10.2uM; HL60; HT_HG-U133A	PRMT8 EXTL3 RECQL5 PLCG1 RARA SLC1A3 PRX PRELID3A DDX3Y	5.72e-05	198	196	9	2715_UP
Drug	Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	SETD1B ACSBG1 AHNAK RECQL5 GNAT2 UBXN1 PRX PRELID3A CDK13	5.72e-05	198	196	9	3223_UP
Drug	Halofantrine hydrochloride [36167-63-2]; Down 200; 7.4uM; HL60; HT_HG-U133A	MAP4 ITPR2 MIA2 IQCK CACNB1 LAMA2 RANBP17 PPP2R1B LRP6	5.72e-05	198	196	9	3130_DN
Drug	Clenbuterol hydrochloride [21898-19-1]; Up 200; 12.8uM; MCF7; HT_HG-U133A	GREB1L AHNAK RECQL5 NME5 FGD1 CACNB1 SZT2 C11orf16 PDE4DIP	5.95e-05	199	196	9	5266_UP
Drug	Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; HL60; HT_HG-U133A	MAP4 ITPR2 REC8 SZT2 MORC2 PPP2R1B PHF3 PDE4DIP LRP6	5.95e-05	199	196	9	2713_DN
Drug	Nifedipine [21829-25-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A	MAP4 PLXND1 EXTL3 TDRKH KDM5A IFT81 RANBP17 CDK13 IL1R1	5.95e-05	199	196	9	6006_DN
Drug	Dichlorphenamide [120-97-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A	BCL9 NME5 TIMELESS PLCG1 TSR1 PDE4DIP IL1R1 KAT6B ARHGAP33	5.95e-05	199	196	9	5286_UP
Drug	prednisolone; Up 200; 1uM; MCF7; HG-U133A	PLXND1 ARHGAP22 RECQL5 ALDH3B2 CACNB1 NVL GTF3C1 PDE4DIP GFM1	5.95e-05	199	196	9	265_UP
Drug	Gleevec; Down 200; 10uM; MCF7; HG-U133A	NPHP4 BNC1 PTPRD DLEC1 CACNB1 KDM5A KRT35 PPP2R1B LRP6	5.95e-05	199	196	9	366_DN
Drug	Clidinium bromide [3485-62-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A	MAP4 BCL9 ITPR2 PTPRS NME5 PLCG1 GNAT2 KPNA5 SMARCC1	5.95e-05	199	196	9	3476_UP
Drug	Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; PC3; HT_HG-U133A	DOHH ITPR2 AHNAK NOS1 TDRKH HTR2C LAMA2 CREB3L1 ARHGAP33	5.95e-05	199	196	9	4197_UP
Drug	Tacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; MCF7; HT_HG-U133A	GREB1L PTPRS NME5 NOS1 TDRKH RARA KDM5A IPO9 PDE4DIP	6.18e-05	200	196	9	2633_UP
Drug	AC1L9GEQ	XDH CREB3L1	7.37e-05	2	196	2	CID000418809
Drug	fulvestrant	NARS1 AHNAK MKI67 TIMELESS DNMT3L KPNB1 PPM1D POLR2B LEFTY1 SMARCB1 SMARCC1 DDX3Y ESPL1 SON	8.30e-05	484	196	14	ctd:C070081
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A	ITPR2 AHNAK RECQL5 TXNIP PHF3 MARF1 LRP6 PBXIP1	1.94e-04	183	196	8	1668_UP
Drug	Monensin sodium salt [22373-78-0]; Up 200; 5.8uM; PC3; HT_HG-U133A	PLXND1 MIA2 RECQL5 NME5 EIF2AK3 PRELID3A PDE4DIP PBXIP1	1.94e-04	183	196	8	3704_UP
Drug	Halcinonide [3093-35-4]; Up 200; 8.8uM; HL60; HT_HG-U133A	ITPR2 FGD1 TIMELESS GNAT2 ALDH3B2 CACNB1 PDE4DIP IL1R1	2.01e-04	184	196	8	2185_UP
Drug	Withaferin A [5119-48-2]; Down 200; 1uM; MCF7; HT_HG-U133A	CALML5 FANCA PLCG1 RARA TXNIP CDK13 PDE4DIP PBXIP1	2.16e-04	186	196	8	3902_DN
Drug	2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester	MASP1 PDE8A PLXND1 MPP4 HEBP1 NME5 ALDH3A1 DNMT3L TDRKH XDH ELP3 SLC1A3 CREB3L1 SFMBT2 PRX NETO2 LRP4 DCLK1	2.25e-04	807	196	18	ctd:C548651
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	NR3C2 REC8 RARA C11orf16 SLC1A3 CREB3L1 PDE4DIP LRP6	2.32e-04	188	196	8	6143_UP
Drug	Methiothepin maleate [19728-88-2]; Up 200; 8.4uM; MCF7; HT_HG-U133A	GREB1L NYNRIN NME5 TDRKH RARA PRELID3A CDK13 PBXIP1	2.41e-04	189	196	8	3231_UP
Drug	Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A	MAP4 RYR2 GNAT2 ALDH3B2 UBXN1 IPO9 KAT6B PBXIP1	2.59e-04	191	196	8	5290_UP
Drug	Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A	SETD1B GREB1L ACSBG1 RARA SZT2 STXBP5L C11orf16 TXNIP	2.59e-04	191	196	8	3392_UP
Drug	Thapsigargin	MAP4 NARS1 DDB1 PTPRD AHNAK MKI67 TIMELESS EIF2AK3 NUP160 REC8 TDRKH COX11 CREB3L1 SFMBT2 IBTK NETO2 PDE4DIP LRRCC1 LRP4 MRPL41 PNPLA7 CTPS1 GFM1 SON HDGF	2.61e-04	1353	196	25	ctd:D019284
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	DOHH MAP4 RYR2 KDM5A TSR1 PHF3 SMARCB1 KAT6B	2.78e-04	193	196	8	2904_DN
Drug	Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; HL60; HT_HG-U133A	MAP4 ITPR2 IQCK REC8 CACNB1 UBXN1 RANBP17 LRP6	2.87e-04	194	196	8	2711_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	MAP4 NOS1 RARA TXNIP PHF3 SMARCC1 LRP6 SON	2.87e-04	194	196	8	4361_DN
Drug	Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	DOHH EXTL3 CALML5 RECQL5 NUP160 TXNIP LRP6 KAT6B	2.87e-04	194	196	8	3840_DN
Drug	Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; MCF7; HT_HG-U133A	SETD1B BCL9 TIMELESS LAMA2 UBXN1 PDE4DIP PBXIP1 ARHGAP33	2.87e-04	194	196	8	5303_UP
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; HL60; HT_HG-U133A	EFL1 KDM5A IBTK PPP2R1B GTF3C1 CDK13 KAT6B PBXIP1	2.87e-04	194	196	8	1264_DN
Drug	17-DMAG; Up 200; 0.1uM; HL60; HT_HG-U133A	MASP1 PTPRD NR3C2 TIMELESS NOS1 REC8 CACNB1 PBXIP1	2.98e-04	195	196	8	6172_UP
Drug	Famotidine [76824-35-6]; Up 200; 11.8uM; PC3; HG-U133A	SETD1B PLXND1 BCL9 SLC30A1 NPHP4 ZNF593 GTF3C1 TSR1	2.98e-04	195	196	8	1946_UP
Drug	radicicol; Up 200; 0.1uM; PC3; HT_HG-U133A	EXTL3 AHNAK NME5 NUP160 SLC1A3 CREB3L1 PDE4DIP ARHGAP33	2.98e-04	195	196	8	5952_UP
Drug	Berberine chloride [633-65-8]; Up 200; 10.8uM; MCF7; HT_HG-U133A	MAP4 ITPR2 SZT2 KDM5A C11orf16 LRP4 LRP6 PBXIP1	2.98e-04	195	196	8	2770_UP
Drug	Myosmine [532-12-7]; Down 200; 27.4uM; HL60; HT_HG-U133A	UBE4B MAP4 PLXND1 PLCG1 NUP160 KPNA5 XDH PDE4DIP	2.98e-04	195	196	8	2199_DN
Drug	Ethopropazine hydrochloride [1094-08-2]; Down 200; 11.4uM; MCF7; HT_HG-U133A	NPHP4 ITPR2 MIA2 NME5 FGD1 NOS1 UBXN1 PBXIP1	2.98e-04	195	196	8	3376_DN
Drug	Raloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; MCF7; HT_HG-U133A	FGD1 TIMELESS ALDH3B2 KDM5A UBXN1 PRELID3A PDE4DIP IL1R1	2.98e-04	195	196	8	6235_UP
Drug	Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; PC3; HT_HG-U133A	ARHGAP22 RECQL5 NME5 TIMELESS KPNA5 RARA UBXN1 LRP6	2.98e-04	195	196	8	4019_DN
Drug	Ricinine [524-40-3]; Down 200; 24.4uM; MCF7; HT_HG-U133A	MAP4 PLXND1 EXTL3 NME5 FKBP15 RARA PRELID3A PPP6R2	2.98e-04	195	196	8	6067_DN
Drug	novobiocin sodium, USP; Down 200; 100uM; SKMEL5; HG-U133A	MAP4 EXTL3 PRR14 MKI67 IFT81 CDK13 PBXIP1 ARHGAP33	2.98e-04	195	196	8	632_DN
Drug	Ambroxol hydrochloride [23828-92-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A	PRMT8 NYNRIN AHNAK NME5 GNAT2 CACNB1 XDH PBXIP1	3.08e-04	196	196	8	3238_UP
Drug	0179445-0000 [211246-22-9]; Down 200; 1uM; MCF7; HT_HG-U133A	EXTL3 CALML5 ITPR2 RECQL5 PLCG1 RARA SMARCC1 ARHGAP33	3.08e-04	196	196	8	3633_DN
Drug	Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A	MAP4 BCL9 RYR2 MORC2 IPO9 IL1R1 KAT6B PBXIP1	3.08e-04	196	196	8	5288_UP
Drug	Guanethidine sulfate [60-02-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A	MASP1 RYR2 PTPRS NYNRIN RECQL5 TIMELESS CACNB1 SZT2	3.08e-04	196	196	8	3171_UP
Drug	Sulfaguanidine [57-67-0]; Up 200; 18.6uM; MCF7; HT_HG-U133A	DOHH EXTL3 PTPRS REC8 CACNB1 PHF3 LRP6 ARHGAP33	3.08e-04	196	196	8	1495_UP
Drug	Pentetic acid [67-43-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A	RECQL5 NME5 GNAT2 LAMA2 C11orf16 PPP2R1B LRP4 PBXIP1	3.08e-04	196	196	8	3387_UP
Drug	haloperidol; Down 200; 10uM; PC3; HT_HG-U133A	PTPRS AHNAK NOS1 LAMA2 REST C11orf16 PBXIP1 ARHGAP33	3.08e-04	196	196	8	4427_DN
Drug	Sulfadoxine [2447-57-6]; Up 200; 12.8uM; PC3; HT_HG-U133A	PLXND1 MIA2 ALDH3A1 XDH UBXN1 PDE4DIP IL1R1 PPP6R2	3.08e-04	196	196	8	5852_UP
Drug	Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; PC3; HT_HG-U133A	PLXND1 ITPR2 GREB1L ACSBG1 NYNRIN AHNAK REC8 PDE4DIP	3.08e-04	196	196	8	4281_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A	SACS KPNB1 MTERF3 TSR1 SMARCB1 CTPS1 KAT6B HDGF	3.08e-04	196	196	8	2035_DN
Drug	Natamycin [7681-93-8]; Up 200; 6uM; MCF7; HT_HG-U133A	REC8 TDRKH POU1F1 REST PPP2R1B IPO9 PDE4DIP PPP6R2	3.08e-04	196	196	8	7167_UP
Drug	Ioxaglic acid [59017-64-0]; Up 200; 3.2uM; MCF7; HT_HG-U133A	MAP4 RYR2 MIA2 RECQL5 NOS1 RARA IPO9 PBXIP1	3.08e-04	196	196	8	7470_UP
Drug	alpha-estradiol; Up 200; 0.01uM; HL60; HT_HG-U133A	EXTL3 NEO1 TIMELESS CACNB1 PHF24 XDH DDX3Y PBXIP1	3.08e-04	196	196	8	6169_UP
Drug	genistein; Up 200; 10uM; HL60; HT_HG-U133A	SRPX2 FGD1 NR3C2 TIMELESS GNAT2 REC8 PDE4DIP PBXIP1	3.08e-04	196	196	8	6194_UP
Drug	Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; PC3; HT_HG-U133A	MAP4 PLXND1 ITPR2 NOS1 PRELID3A PHF3 CDK13 DDX3Y	3.08e-04	196	196	8	4342_UP
Drug	Tocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A	MAP4 PTPRS RECQL5 NOS1 XDH REST PRELID3A PHF3	3.19e-04	197	196	8	7351_UP
Drug	Sulpiride [15676-16-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	DOHH ABCA3 RYR2 ARHGAP22 ALDH3B2 CACNB1 POU1F1 UBXN1	3.19e-04	197	196	8	4566_UP
Drug	Betulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A	SLC30A1 PTPRD AHNAK STXBP5L UBXN1 TXNIP GUCY1A2 A4GNT	3.19e-04	197	196	8	4181_UP
Drug	Dydrogesterone [152-62-5]; Up 200; 12.8uM; HL60; HT_HG-U133A	MAP4 MIA2 AHNAK REC8 C11orf16 SLC1A3 PRELID3A PDE4DIP	3.19e-04	197	196	8	2156_UP
Drug	Diphenidol hydrochloride [3254-89-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A	MAP4 FANCA MIA2 RECQL5 NOS1 RARA XDH ARHGAP33	3.19e-04	197	196	8	7447_UP
Drug	Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A	MAP4 CAMTA2 RYR2 PTPRS NOS1 KDM5A REST CDK13	3.19e-04	197	196	8	2307_DN
Drug	Epirizole [18694-40-1]; Up 200; 17uM; PC3; HT_HG-U133A	DOHH ABCA3 PLXND1 MIA2 NR3C2 KDM5A PDE4DIP PBXIP1	3.19e-04	197	196	8	7292_UP
Drug	Fenofibrate [49562-28-9]; Up 200; 11uM; MCF7; HT_HG-U133A	SOCS7 ITPR2 MIA2 PTPRS CACNB1 RARA XDH CDK13	3.19e-04	197	196	8	7474_UP
Drug	0393-0188; Up 200; 10uM; PC3; HT_HG-U133A	UBE4B PLXND1 ITPR2 AHNAK PRELID3A PHF3 CDK13 PBXIP1	3.19e-04	197	196	8	7510_UP
Drug	SR-95639A [115767-94-7]; Down 200; 10uM; MCF7; HT_HG-U133A	RYR2 ITPR2 FGD1 GNAT2 IQCK TDRKH UBXN1 PDE4DIP	3.19e-04	197	196	8	4977_DN
Disease	Sjogren-Larsson syndrome (implicated_via_orthology)	ALDH3A1 ALDH3B1 ALDH3B2	5.18e-06	6	190	3	DOID:14501 (implicated_via_orthology)
Disease	Malignant neoplasm of salivary gland	FANCA NETO2 ESPL1 SON	2.02e-04	45	190	4	C0220636
Disease	urate measurement, bone density	UBE4B LIN54 KATNAL1 ITPR2 FANCA ARHGAP22 PTPRD NR3C2 DDX12P SFMBT2 RANBP17 KAT6B DCLK1	2.03e-04	619	190	13	EFO_0003923, EFO_0004531
Disease	Malignant neoplasm of breast	ABCA3 RXRB GPR180 PTPRD MIA2 MKI67 TIMELESS DLEC1 KPNA5 RARA PPM1D YY2 LAMA2 XDH ELP3 PALB2 GUCY1A2 KAT6B	2.14e-04	1074	190	18	C0006142
Disease	hydrocephalus (implicated_via_orthology)	NME5 AK8 HYDIN	2.36e-04	19	190	3	DOID:10908 (implicated_via_orthology)
Disease	Salivary Gland Neoplasms	FANCA NETO2 ESPL1 SON	2.39e-04	47	190	4	C0036095
Disease	Endometrial Stromal Sarcoma	NUTM2A NUTM2B	4.07e-04	5	190	2	C0206630
Disease	Clear cell sarcoma of kidney	NUTM2B NUTM2E	6.08e-04	6	190	2	C0334488
Disease	chronic obstructive pulmonary disease, CC16 measurement	AHNAK APIP	6.08e-04	6	190	2	EFO_0000341, EFO_0005080
Disease	erythrocyte aggregation	C12orf42 SFMBT2	6.08e-04	6	190	2	EFO_0803375
Disease	azoospermia (implicated_via_orthology)	PTPRD PTPRS TDRKH	6.86e-04	27	190	3	DOID:14227 (implicated_via_orthology)
Disease	Disease Exacerbation	DDB1 RXRB MKI67 UBXN1 ZNF593 TXNIP	7.22e-04	165	190	6	C0235874
Disease	free cholesterol measurement	NYNRIN NUP160 KPNB1 PPP6R2 CEACAM20	8.40e-04	113	190	5	EFO_0008591
Disease	Unilateral agenesis of kidney	GREB1L FREM2	1.13e-03	8	190	2	C0266294
Disease	Neurobehavioral Manifestations	UBE4B NOS1	2.61e-03	12	190	2	C0525041
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	NYNRIN PLCG1 KPNB1 DNAH10 SLC22A2 PPP6R2	2.78e-03	215	190	6	EFO_0008317, EFO_0008591
Disease	interleukin 17 measurement	EXTL3 FANCA NUP160	3.06e-03	45	190	3	EFO_0008174
Disease	fibrinogen measurement, tissue plasminogen activator measurement	PLXND1 HECTD4 IL1R1	3.06e-03	45	190	3	EFO_0004623, EFO_0004791
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	NYNRIN PLCG1 KPNB1 DNAH10 SLC22A2 PPP6R2	3.11e-03	220	190	6	EFO_0004529, EFO_0008317
Disease	total lipids in small LDL	NYNRIN KPNB1 SLC22A2	3.46e-03	47	190	3	EFO_0022168
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	NYNRIN PLCG1 KPNB1 DNAH10 PPP6R2 CEACAM20	3.47e-03	225	190	6	EFO_0008317, EFO_0010351
Disease	pulse pressure measurement, social deprivation	VTI1A CTPS1	3.57e-03	14	190	2	EFO_0005763, EFO_0009696
Disease	Fanconi anemia	FANCA PALB2	3.57e-03	14	190	2	cv:C0015625
Disease	Adenoid Cystic Carcinoma	FANCA NETO2 ESPL1 SON	4.04e-03	100	190	4	C0010606
Disease	third ventricle volume measurement	PTPRD GUCY1A2	4.10e-03	15	190	2	EFO_0010335
Disease	Fetal Alcohol Syndrome	NOS1 REST	5.26e-03	17	190	2	C0015923
Disease	remnant cholesterol measurement	NYNRIN KPNB1 PPP6R2 CEACAM20	5.30e-03	108	190	4	EFO_0010815
Disease	aortic measurement	MASP1 LIN54 RYR2 ARHGAP22 VTI1A MORC2	5.88e-03	251	190	6	EFO_0020865
Disease	Bone marrow hypocellularity	FANCA PALB2	5.90e-03	18	190	2	C1855710
Disease	parahippocampal gyrus volume measurement	FREM2 XDH	5.90e-03	18	190	2	EFO_0010318
Disease	Tourette syndrome, schizophrenia	DNAH10 PHF3	5.90e-03	18	190	2	EFO_0004895, MONDO_0005090
Disease	Colorectal Carcinoma	ABCA3 PTPRD SACS PTPRS MKI67 NR3C2 CACNB1 VTI1A PPP2R1B GUCY1A2 DCLK1	6.03e-03	702	190	11	C0009402
Disease	alkaline phosphatase measurement	MAP4 SLC30A1 GPR180 PRR14 NYNRIN AHNAK NR3C2 NUP160 NBPF3 SLC1A3 AK8 SLC4A1AP SLC22A2 PPP6R2	6.25e-03	1015	190	14	EFO_0004533

Protein segments in the cluster

Peptide	Gene	Start	Entry
PIEDRETIIMNQILP	PPP2R1B	326	P30154
MEEQDARVPALEPFR	ALKBH6	1	Q3KRA9
IVEFMRISPEPLDQV	C2orf16	471	Q68DN1
ERIMEFSAPLPLENE	CEP170	601	Q5SW79
VVMHPTPQVDELDIL	BTBD10	441	Q9BSF8
LVEEAQTPVMLPQDS	C1orf167	56	Q5SNV9
EMTQLPVIKAEPLEV	CREB3L1	176	Q96BA8
MEINREVEELPEKPS	ANKRD30B	516	Q9BXX2
VMSTPITEEQRPERE	C2orf78	866	A6NCI8
PPEMFDIILDENQLE	CACNB1	381	Q02641
SPMERPEAINIIENA	EIF2AK3	1061	Q9NZJ5
DVASRFLEMEPVTIP	DNMT3L	296	Q9UJW3
IAPTVLVDVQEMEPV	ALDH3B1	316	P43353
LTDVDPQSPVMQEEI	ALDH3A1	321	P30838
IRVELMQPPDLPEET	CEACAM20	521	Q6UY09
LSVRAMPLPEEVTQI	EFL1	751	Q7Z2Z2
MPLPEEVTQILEENS	EFL1	756	Q7Z2Z2
EPQSEPVRVLDMVAK	FBXO34	271	Q9NWN3
MDTDVISIRPIPEEN	A4GNT	166	Q9UNA3
EPGIEMQVENLELPV	HTR2C	431	P28335
TEQTPALIMVPREVE	BNC1	636	Q01954
ADSPQAVDVIPVDMI	CAMTA2	926	O94983
RMPVLPEDQDVADER	ABCA3	1351	Q99758
PEVEGKLEVPDMNIR	AHNAK	2476	Q09666
RDVAMKEPLVDIVDP	PRMT8	251	Q9NR22
LPDQMVVEISRSFPE	DEPDC7	276	Q96QD5
APTVLVDVQETEPVM	ALDH3B2	236	P48448
GQPLPQEELDAMIRE	CALML5	111	Q9NZT1
QHQDMRILELTPEPD	CDK13	1236	Q14004
IPMLVDVLQDTRQEP	DOHH	71	Q9BU89
LSAEVELQMTPDPEV	ATG2B	1726	Q96BY7
VEIPPKDIMAELESE	ASXL3	426	Q9C0F0
VPIPEEEVVTTDMVQ	KPNA5	76	O15131
VSRVSPLPVEQRMDI	RANBP17	71	Q9H2T7
PIRMLEIEGERELPE	REC8	201	O95072
DLEQPDRVDMLQEPL	RARA	341	P10276
KQEPVITVAPVEEML	IQCK	76	Q8N0W5
EELTMAILAPVRNPD	NVL	591	O15381
TSIPIDTDEERPVML	ITPR2	401	Q14571
TMIEVLISDVNDNPP	PCDHB1	436	Q9Y5F3
VRVVDVNDNPPEIAM	PCDHB18P	281	Q96TA0
PEEARLGMPVSLEEQ	KASH5	21	Q8N6L0
ERPMPQLEPTCEIEV	KAT6B	1166	Q8WYB5
DMVRIESPEEISLLP	MTHFS	91	P49914
PMEVVQKEPVQIELS	REST	736	Q13127
PTLDRADMEELVIPT	LEFTY1	41	O75610
EKNIVVMEEVVITPP	LSM12	131	Q3MHD2
MEVVPAEVNSLLPEE	LIN54	1	Q6MZP7
SPIPMETELEEIVNI	LIN54	36	Q6MZP7
PSPVMVLENIEPEIV	NR3C2	736	P08235
IEMASEERPPAQALE	MAP4	226	P27816
GALPDPEIVRMVEAR	NRAP	136	Q86VF7
SPPVVDLRTIMEIEE	IBTK	1116	Q9P2D0
VIPVDDETPRMTINN	FREM2	1296	Q5SZK8
EIPRAMEVEVEELLP	FER1L4	401	A9Z1Z3
MEVEVEELLPLPENV	FER1L4	406	A9Z1Z3
PNIVLLIEEMDVPTE	DCLK1	446	O15075
PESEIQNRLMVPEDI	AK8	196	Q96MA6
PAMTVLPSEIDVRQE	PLXND1	601	Q9Y4D7
LDDVPPRIARAMENE	PDE8A	481	O60658
EREIRFMFPEVIVEP	NME5	136	P56597
MVPSEQVVEEAVPLP	FKBP15	981	Q5T1M5
EAATLEVERPLPMEV	HDGF	181	P51858
LPDNIPESEEAMRIV	MPP4	141	Q96JB8
RMVIDEQQSPDIILP	LRP6	946	O75581
VEDIQTKLPPMSEEL	LAMA2	1856	P24043
AAPPVDLNRVLEEMR	KRT35	256	Q92764
RLRCMPAPEEIVEEL	MKI67	3011	P46013
TRVVEISIMEPDVPL	PGAP6	186	Q9HCN3
MEDVTQIVVEPEPTA	PPM1D	21	O15297
VEDIPFEMVLLNPDA	GPR180	141	Q86V85
RPSIKEVIQPDVMEE	HECTD4	891	Q9Y4D8
PDQVPLREEFEQIML	GREB1L	466	Q9C091
EVMRELAPELFESQP	KDM5A	516	P29375
EIVSRIEPAKPAMVD	PNPLA7	1241	Q6ZV29
PQVVVLVPEMDVALT	NPHP4	301	O75161
IPENTPETVVMVFRI	PCDHB12	356	Q9Y5F1
EPELDIISNPRDIQM	MORC2	211	Q9Y6X9
IRETPMVLELTPQIV	MTERF2	316	Q49AM1
IVEVLEEFPSIQMPA	NOS1	1151	P29475
TPEDDMPVGRNVLEL	PTPRS	286	Q13332
LMPPEETILTFAEVQ	PALB2	1006	Q86YC2
CPRLNEVLMEAEEPE	NBPF3	551	Q9H094
DIVSVIDMPPTEDRS	ARHGAP33	211	O14559
GPEIMRTIPEEELTD	ESPL1	1481	Q14674
PLSPKVVTEEEVNRM	HYDIN	31	Q4G0P3
DPKQLVDIREEMPEQ	IFT81	46	Q8WYA0
EPLAGPELDEMLREV	CABP4	241	P57796
EEVVEPPSNLIAMEV	COL12A1	331	Q99715
EEQRLNPQEEVDMPV	COX11	221	Q9Y6N1
VMINDEPVSAAPRER	FRMPD4	121	Q14CM0
DVTLPLMSVPEIRAV	GALT	136	P07902
METLTRITEELVPVP	SLC1A3	221	P43003
LVGEMQEPVVLRPAE	EXTL3	241	O43909
TVEPEKMPQVTVDVL	FANCA	256	O15360
MPSVFTDPDLQEVIR	BCL9	1211	O00512
LISPELFIPVEDDVM	DPP8	406	Q6V1X1
MLETGPEAERPEQLE	DDX12P	196	Q92771
VPIEEAVKMELPIIS	ACSBG1	581	Q96GR2
MPILREEDEIEPRPV	CATIP	271	Q7Z7H3
MPDLPNVGLERDIEQ	ELP3	286	Q9H9T3
ENVHPDVMLVQPRVE	KPNB1	781	Q14974
IQFEERPQEPSEIMI	MARF1	1651	Q9Y4F3
RPQEPSEIMILNQEE	MARF1	1656	Q9Y4F3
RFPETLMEIEIPIVD	MASP1	596	P48740
EVTDTQMPLVAPVIL	IPO9	176	Q96P70
PEMVELVNIEPVCVR	DDHD1	246	Q8NEL9
VIMRDIPELPHTELE	FAM135B	261	Q49AJ0
ENPEMEGPERDQLVI	GOLM1	311	Q8NBJ4
MPQVPDKIIEVLEFS	GPR139	96	Q6DWJ6
EPQIRRIVEQDTMPP	DDX3Y	356	O15523
RPQLEEAPLTVESDM	DVL1P1	376	P54792
DEIVMVIKDSPQTIP	CASP14	146	P31944
VLQMVLEEVPEPVSS	DLEC1	711	Q9Y238
MVPEEVEVEIDEIPV	DNAH10	1	Q8IVF4
LEPIMAVEVVAPNEF	GFM1	646	Q96RP9
ALPETIEEAENMQRP	SLC22A2	521	O15244
VEPIILVHEDIPMKT	SACS	1416	Q9NZJ4
PNIPSLEKLMEEIVE	RYR2	3206	Q92736
PVIVSPANETMEVDL	IL1R1	226	P14778
DAEPTVRTELMEQIP	PPP4R1L	96	Q9P1A2
NVEAEASMVIAVPEP	DDB1	211	Q16531
ITQDPPLDMEEKVRF	PPP6R2	61	O75170
GPLESLPNMEEVREE	NYNRIN	981	Q9P2P1
LTPEDDMPIGRNVLE	PTPRD	276	P23468
PMQPISEEEAIQIIA	MTERF3	121	Q96E29
VESMEQDRIPEVHVP	MIA2	201	Q96PC5
DDMLVVPIIENTPEE	APIP	156	Q96GX9
EEVLTPDGRPIQMRI	GUCY1A2	601	P33402
EIPPEVVQEYVDIME	NUTM2A	511	Q8IVF1
EIPPEVVQEYVDIME	NUTM2B	511	A6NNL0
EIPPEVVQEYVDIME	NUTM2E	511	B1AL46
MRPLDIVELAEPEEV	MRFAP1	1	Q9Y605
PEPEVEEAGQVFLLM	SZT2	6	Q5T011
PEEIRALSKEELQMP	KATNAL1	441	Q9BW62
VQIKEMVPEFVVPDL	MRPL41	51	Q8IXM3
RPDRQPEFTQIDIEM	DARS2	271	Q6PI48
MEGVVVPLQDLRVIP	SLC6A19	436	Q695T7
LADVLPEEMPITVLQ	STRIP2	541	Q9ULQ0
EAPERLMTDTINEPI	NARS1	421	O43776
PRLNSVLMEVEEPEV	NBPF8	826	Q3BBV2
PRLNSVLMEVEEPEV	NBPF12	1376	Q5TAG4
CPRLNSVLMEVEEPE	NBPF19	3761	A0A087WUL8
PRLNGVLMEVEEPEV	NBPF20	5126	P0DPF2
KLVEEPIDMDSPEIR	POU1F1	116	P28069
PVSATPDERIMELVL	PRDM15	671	P57071
EGTMPPELVEVIRRL	GNAT2	116	P19087
DRAPQPTLVVMLEDI	PRR14	146	Q9BWN1
PVPLMERQESVELTV	FGD1	356	P98174
VPSAPEVQETTRMLE	NEO1	1416	Q92859
PENPEMTVLTQEAII	PRELID3A	116	Q96N28
MRQALIPVDEDGLEP	CTPS1	126	P17812
IQMSVQRIVEDAPPI	POLR2B	51	P30876
PDEVFLEEAPLVRMR	SHROOM1	386	Q2M3G4
SQPEVLVPIRLDMEI	SMARCB1	181	Q12824
IDPSPESHEVMERIL	SGO2	1086	Q562F6
PMVAVAEPVRVVVLD	SLC26A10	456	Q8NG04
IETEAVAPEERPSML	SETD1B	1236	Q9UPS6
CPEQALEDRVMEEIP	NETO2	491	Q8NC67
FMQPLPEEEIVIRDD	NUP160	436	Q12769
LEPREPVVNDEMCDV	PHF24	121	Q9UPV7
MEDPTPVPNIEEVVL	SMARCC1	371	Q92922
LADEQRFTEPVMVLP	STXBP5L	871	Q9Y2K9
ILRPQVEDPVTIMEG	ARHGAP22	316	Q7Z5H3
PEEMPVDRILEAELA	RXRB	296	P28702
VLMTEPSLNPREIRE	ACTRT1	106	Q8TDG2
VSEMAVLLIDPEPQI	NCAPD2	1131	Q15021
ELEPEERMAVPAGAQ	C12orf42	241	Q96LP6
VMARELPELEPTAQL	C11orf16	301	Q9NQ32
ITQQMEEIVRPLGPE	ATP11B	226	Q9Y2G3
ELMETTRIREQAPQP	RECQL5	671	O94762
LVPEAEPEEMARQLL	TMEM268	276	Q5VZI3
AVPLVPLTEENEEAM	TIMELESS	1041	Q9UNS1
VLMEEPPERDSTVAV	SCN2B	146	O60939
RQESLQAEVIPDPME	TSR1	351	Q2NL82
IPAVIEQPLEEERMH	TTC30B	626	Q8N4P2
PEDIEENRAVPDMLK	TDRKH	496	Q9Y2W6
ETGPMEEVERQVLPD	PBXIP1	221	Q96AQ6
IDRDRYMEPVTPEEI	SRPX2	426	O60687
LEPDMILRPSIEEVS	TSSK3	246	Q96PN8
DTPATIPREVEMEII	STOX2	301	Q9P2F5
VPEMAVPEVRLPEVE	PRX	481	Q9BXM0
PEMAVPEVRLPEVQL	PRX	671	Q9BXM0
PQLPAVEIEEGRLEM	PRX	906	Q9BXM0
TESMLEPVPELKEQI	UBE4B	1276	O95155
LLEQMDLEVREIPPQ	VTI1A	51	Q96AJ9
FPVESEAVMEDVLRP	SRA1	91	Q9HD15
ELHDINVEPLPMEDI	YY2	21	O15391
QTPVPEVIVDVESMD	SFMBT2	446	Q5VUG0
MSVPEEEERLLPLTQ	SLC25A27	1	O95847
NLQEDLPTAVEPLME	PHF3	1416	Q92576
VEEMVNPVALEPERE	PLCG1	846	P19174
TLLRNQPEPTMEEIE	XDH	126	P47989
EADMERPLQELGLVP	UBXN1	271	Q04323
MVFRNVGRPPEEEDV	SOCS7	1	O14512
RLAVPTEVSTEVPEM	ZNF593	116	O00488
IPAVIEQPLEEERMH	TTC30A	626	Q86WT1
LPPEQQTDDLLRMTE	PSMD5	371	Q16401
PPLEVSEEQVARLME	UBAC2	301	Q8NBM4
IERFIEPHEMQQPLV	SLC30A1	101	Q9Y6M5
TVPPVDIVFERDMLT	GTF3C1	356	Q12789
VDLVDVNTPDLMAPV	TXNIP	146	Q9H3M7
DEEIPVVVPMQIELL	UHRF1BP1	1306	Q6BDS2
LPEQPAVTVAMELTE	SON	491	P18583
PVIPEVRLNCMETFE	UNC79	1576	Q9P2D8
VTDKPVDEALREAMP	HEBP1	46	Q9NRV9
ENLDRPRDIVVEPMG	LRP4	856	O75096
IIDRMPVITAPIDEL	LRRCC1	241	Q9C099
RPQPEIEPEAAVQEM	SLC4A1AP	676	Q9BWU0
PEDIPAMERLTQEVL	PDE4DIP	821	Q5VU43